Immunoreactive pancreatic secretory trypsin inhibitor in gynecological diseases

Murata, A.; Ogawa, M.; Matsuda, K.; Matsuura, N.; Kosaki, G.; Inoue, M.; Ueda, G.; Kurachi, K.

Research Communications in Chemical Pathology and Pharmacology 41(3): 493-499

1983


ISSN/ISBN: 0034-5164
PMID: 6195699
Document Number: 211615
Serum immunoreactive pancreatic secretory trypsin inhibitor in 45 patients with various gynecological diseases was measured by a radioimmunoassay. In normal serum of healthy individuals, the concentration was 11.7 +/- 2.3 ng/ml (mean +/- SD). Elevated levels (above control mean plus 3 S.D.) were observed in sera of 5 patients (50%) with ovarian cancer, and serum of one patient (4.7%) with uterine cancer. Only one tumor extract of ovarian cancer contained a significant level of immunoreactive PSTI. PSTI-containing mucin was detected in a mucin-producing ovarian adenocarcinoma.

Document emailed within 1 workday
Secure & encrypted payments